3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide

C41H44F2N12O4 — CID 176796654

IUPAC3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide
SMILESCC(C)(O)c1nc2nn(C3CCC(N4CCN(C5CN(c6cc(F)c(N7CCC(=O)NC7=O)c(F)c6)C5)CC4)CC3)cc2cc1NC(=O)c1ccc2cc(C#N)cnn12
InChIInChI=1S/C41H44F2N12O4/c1-41(2,59)37-33(46-39(57)34-8-7-28-15-24(19-44)20-45-55(28)34)16-25-21-54(49-38(25)48-37)27-5-3-26(4-6-27)50-11-13-51(14-12-50)30-22-52(23-30)29-17-31(42)36(32(43)18-29)53-10-9-35(56)47-40(53)58/h7-8,15-18,20-21,26-27,30,59H,3-6,9-14,22-23H2,1-2H3,(H,46,57)(H,47,56,58)
InChIKeyDQDVSDGIKIYSGS-UHFFFAOYSA-N
MW806.88 g/mol
LogP4.14
Rot. Bonds8

About 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide

3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide (PubChem CID 176796654) has the molecular formula C41H44F2N12O4 and a molecular weight of 806.88 g/mol. Its IUPAC name is 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide.

Molecular Properties

Compound Name3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide
PubChem CID176796654
Molecular FormulaC41H44F2N12O4
Molecular Weight806.88 g/mol
Exact Mass806.36
IUPAC Name3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide
SMILESCC(C)(O)c1nc2nn(C3CCC(N4CCN(C5CN(c6cc(F)c(N7CCC(=O)NC7=O)c(F)c6)C5)CC4)CC3)cc2cc1NC(=O)c1ccc2cc(C#N)cnn12
InChIInChI=1S/C41H44F2N12O4/c1-41(2,59)37-33(46-39(57)34-8-7-28-15-24(19-44)20-45-55(28)34)16-25-21-54(49-38(25)48-37)27-5-3-26(4-6-27)50-11-13-51(14-12-50)30-22-52(23-30)29-17-31(42)36(32(43)18-29)53-10-9-35(56)47-40(53)58/h7-8,15-18,20-21,26-27,30,59H,3-6,9-14,22-23H2,1-2H3,(H,46,57)(H,47,56,58)
InChIKeyDQDVSDGIKIYSGS-UHFFFAOYSA-N
XLogP4.14
TPSA180.26 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds8
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500806.88
LogP ≤ 54.14
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Analyze 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide?
The IUPAC name of 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide (CID 176796654) is 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide.
What is the SMILES notation for 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide?
The canonical SMILES for 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide is CC(C)(O)c1nc2nn(C3CCC(N4CCN(C5CN(c6cc(F)c(N7CCC(=O)NC7=O)c(F)c6)C5)CC4)CC3)cc2cc1NC(=O)c1ccc2cc(C#N)cnn12.
What is the InChIKey of 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide?
The InChIKey is DQDVSDGIKIYSGS-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H44F2N12O4/c1-41(2,59)37-33(46-39(57)34-8-7-28-15-24(19-44)20-45-55(28)34)16-25-21-54(49-38(25)48-37)27-5-3-26(4-6-27)50-11-13-51(14-12-50)30-22-52(23-30)29-17-31(42)36(32(43)18-29)53-10-9-35(56)47-40(53)58/h7-8,15-18,20-21,26-27,30,59H,3-6,9-14,22-23H2,1-2H3,(H,46,57)(H,47,56,58).
What are the key properties of 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide?
3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide has a molecular weight of 806.88 g/mol, XLogP of 4.14, 8 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 3-cyano-N-[2-[4-[4-[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)-3,5-difluorophenyl]azetidin-3-yl]piperazin-1-yl]cyclohexyl]-6-(2-hydroxypropan-2-yl)pyrazolo[3,4-b]pyridin-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide is sourced from PubChem (CID 176796654), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).